Navigation Links
United BioSource Corporation and CogState Ltd. Form Strategic Partnership to Support Cognitive Assessment in Clinical Research

UBC Makes Strategic Investment in CogState Ltd. to Support Partnership Comprehensive service will standardize administration, measurement and

global implementation of cognitive testing in clinical trials

BETHESDA, Md., Aug. 5 /PRNewswire/ --

Key points:

-- United BioSource Corporation (UBC) and CogState Ltd. enter into a strategic partnership to facilitate the use of cognitive testing in clinical trials.

-- UBC has made a direct investment in CogState to support current and anticipated growth.

(Logo: )

United BioSource Corporation (UBC) today announces that on July 28, 2008, it entered into a strategic partnership with CogState Ltd. to increase the ability for pharmaceutical and life sciences companies to conduct cognitive testing in clinical trials. Customers will be able to leverage both companies' scientific resources, software capabilities and global operations to support full-scale clinical development programs.

Cognitive impairment is a defining aspect of many psychiatric and neurological diseases, including Alzheimer's disease, schizophrenia, Parkinson's disease, ADHD, depression and stroke. Consequently, improving cognition has become an important outcome for new treatment strategies in these conditions and there is a need for sensitive measures, assays and analyses that can be used to guide decisions about cognition. Furthermore there is also a need for systems that can be used to cost-effectively manage the use of cognitive assessments in multi-national clinical trials.

Within this context, UBC and CogState have partnered to advance the field of cognitive assessment in clinical trials through provision of an integrated cognitive testing solution for use in Phase I through IV clinical trials internationally. The comprehensive cognitive service solution offered by the partnership will provide new opportunities for sponsor companies seeking the global, operational depth of UBC coupled with the power of CogState's industry-leading cognitive testing expertise.

CogState has earned a solid reputation in scientific research for its standard and customized test batteries, as well as its reliable computerized testing systems and methods of analysis of cognitive data. It has proven itself as a leader in cognition testing and offers sponsor companies the most innovative and appropriate cognitive assessment strategies, including computerized testing, traditional paper and pencil batteries, such as the Neuropsychological Test Battery (NTB) developed by Dr. John Harrison, Principal Scientist for CogState Ltd. CogState clinical trials systems also include real-time data reporting programs which provide investigators with new opportunities for both immediate data read-out and monitoring data quality.

In response to the increasing focus on cognitive assessment within clinical trials, CogState sought out an established, global pharmaceutical services company with a proven methodology for ensuring data quality in clinical trials. "UBC's customized, hands-on approach to rater training, assessment and ongoing rater surveillance is a perfect fit with CogState's portfolio of evidence-based cognitive testing capabilities," said Brad O'Connor, CEO of CogState.

UBC's leading Ratings Services group is focused on standardizing the administration and scoring of clinically subjective outcome measures used as pivotal endpoints in clinical trials. Its data collection, data monitoring and training services are designed to reduce data variance and maximize inter-site reliability across countries. UBC has trained, certified and monitored more than 20,000 raters, testers and investigators in more than 60 countries encompassing over 400 protocols.

Catherine Spear, Senior Vice-President of UBC's Ratings Services group states, "UBC and CogState have demonstrated an unsurpassed commitment to ensuring measurement precision and data quality within clinical research. Our combined offering will provide customers with a comprehensive solution for cognitive testing that addresses both the operational and scientific challenges associated with clinical research. Sponsor companies will be better equipped to select the most appropriate cognitive tests; train, certify and support raters and testers administering the batteries; centrally monitor test data; and interpret test results. Ultimately, companies will be able to improve the timeliness, effectiveness and precision of their trials that include cognitive testing."

Enthusiasm for this new partnership is felt by the scientific leaders at both organizations. "We are excited about offering comprehensive global training and operational services from UBC to our customers and we look forward to supporting UBC customers with our innovative cognitive testing tools. The UBC global project delivery capabilities are unmatched in the pharmaceutical services industry," said CogState Principal Scientist Paul Maruff, PhD.

David Miller, MD, a UBC Practice Leader with a specialty in dementia trials and other neurological disorders, says, "CogState's validated, evidence-based platform for cognitive testing together with UBC's proven training, certification and data monitoring methodology will provide sponsor companies with unparalleled support."

"The growing importance of cognition as a pivotal endpoint in clinical development has increased the need for scalable, evidence-based cognitive testing solutions," stated Professor Peter Snyder, a leading international researcher in Alzheimer's disease, Professor of Clinical Neuroscience at Brown University and scientific consultant to CogState. "By seamlessly integrating science, technology and client service, the combination of UBC and CogState will be able to offer the most complete and integrated cognitive testing approach to pharmaceutical and life sciences companies," added Professor Snyder.

CogState and UBC will remain independent legal entities and will maintain their respective company names. Likewise, the executive management will also remain the same for both companies. The partnership will allow CogState to more efficiently deliver training and site support, thereby further assuring the quality of data. UBC and CogState will immediately begin to work together to support sponsor companies with the assessment of cognition in clinical trials.

About United BioSource Corporation (UBC)

UBC is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in offering new and innovative ways to study drugs and devices by providing expertise in science, strategy and execution.

UBC is headquartered in Bethesda, Maryland, with offices in the United States, Canada, Eastern and Western Europe and South America. For more information, visit or call +866-458-1096.

About CogState:

CogState Ltd. (ASX: CGS) specializes in the development and commercialization of rapid, computerized tests of cognition (brain function). The tests are sold to pharmaceutical, biotechnology, nutraceutical and functional food companies to quantify the effect of drugs or other interventions on human subjects participating in clinical trials.

Tess Drahzal

+1 (866) 458-1096

SOURCE United BioSource Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. United Therapeutics Reports Second Quarter 2008 Financial Results
2. Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent
3. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
4. United Therapeutics to Announce Second Quarter 2008 Financial Results Before Market Open on Thursday, July 31, 2008
5. Animetrics Inc. Selected to Provide 3D Face Viewer Technology for United States Army Biometric Automated Toolset (BAT)
6. Warburg Pincus Acquires 5.4% of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank
7. Genzyme Files Applications for Approval of Mozobil in the United States and Europe
8. Sturgeon and Caviar From Aquaculture: United Food Technologies AG Hands Over Turnkey Plant
9. United Therapeutics Announces the Results of Its 2008 Annual Meeting of Shareholders
10. United Therapeutics Reports First Quarter 2008 Financial Results
11. United Therapeutics to Announce First Quarter 2008 Financial Results Before Market Open on Thursday, May 1, 2008
Post Your Comments:
(Date:11/24/2015)... 2015 Cepheid (NASDAQ: CPHD ) today ... following conference, and invited investors to participate via webcast. ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ... New York, NY      Tuesday, December 1, 2015 ...
(Date:11/24/2015)... ... November 24, 2015 , ... International ... and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. ... 2015, where ISPE hosted the largest number of attendees in more than a ...
(Date:11/24/2015)... ... ... This fall, global software solutions leader SAP and AdVenture Capital brought together ... their BIG ideas to improve health and wellness in their schools. , Now, the ... title of SAP's Teen Innovator, an all-expenses paid trip to Super Bowl 50, and ...
(Date:11/24/2015)... Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders ... Israel time, at the law offices of Goldfarb Seligman ... Floor, Tel Aviv, Israel . ... to the Board of Directors; , election of Liat ... an amendment to certain terms of options granted to our Chief Executive ...
Breaking Biology Technology:
(Date:11/9/2015)... SAN JOSE, Calif. , Nov. 9, 2015 /PRNewswire/ ... of human interface solutions, today announced broader entry into ... of vehicle-specific solutions that match the pace of consumer ... drivers, and biometric sensors are ideal for the automotive ... the vehicle. Europe , ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
(Date:10/29/2015)... , October 29, 2015 ... authentication company focused on the growing mobile commerce ... announces that StackCommerce, a leading marketplace to discover ... the Wocket® smart wallet on StackSocial for this ... ("NXT-ID" or the "Company"), a biometric authentication company ...
Breaking Biology News(10 mins):